Experience

ieso

• United Kingdom
• Mental Health Care
• 100 - 200 Employee

• Business Development Manager

  • Sep 2020 - Present



Napp Pharmaceuticals Limited

• United Kingdom
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Key Account Manager and Training Associate

  • Jan 2000 - Apr 2020

  Full responsibility for launching a new respiratory device across Scotland including KOL development, meds management, formulary applications and pull through. Oct 2018 to present.Previous therapy areas of Diabetes, Cardiovascular and Pain Management. Full responsibility for launching a new respiratory device across Scotland including KOL development, meds management, formulary applications and pull through. Oct 2018 to present.Previous therapy areas of Diabetes, Cardiovascular and Pain Management.



British Heart Foundation

• United Kingdom
• Non-profit Organizations
• 700 & Above Employee

• Research Scientist

  • Aug 1994 - Dec 1999

  Investigating the use of L-Glutamine as a cardioprotective agent in ischaemic heart disease.(Khogali et al, J Mol Cell Cardiol 30, 819-827, 1998) Investigating the use of L-Glutamine as a cardioprotective agent in ischaemic heart disease.(Khogali et al, J Mol Cell Cardiol 30, 819-827, 1998)